Tailored organosolv banana peels lignins: Improved thermal, antioxidant and antimicrobial performances by controlling process parameters.

There is a growing environmental concern in the world for replacing the traditional petroleum-based products. The aim of this work was to evaluate the structure - property relationship of banana peel lignins (BPLs) as antioxidant and antimicrobial agents by controlling the parameters of organosolv process. The milled banana peel was hydrolyzed using an aqueous acetic acid solution (70, 80 and 90% v/v) and 2.0% v/v HCl at 110 °C for 1, 2 and 3 h. BPLs were characterized by FTIR, 1H NMR, 1H13C HSQC, 31P NMR, GPC and TGA. The antioxidant capacity of BPLs was evaluated by DPPH, ABTS and H2O2 assays, comparing their performance with that of ascorbic and gallic acid. The antimicrobial activity of BPLs was evaluated against E. coli. The reaction time and acetic acid/water ratio had significant effects on the yield and purity of BPLs. The composition of organosolv solution also affected their total amount of hydroxyls (0.71-0.82 mmol g-1), Mw (2759-3954 g mol-1), Tonset (232-254 °C), antioxidant and antimicrobial activities. It can be concluded that the control of organosolv parameters can be a useful tool for tuning the structural features of lignins and to maximize their performance.

Antinociceptive effect of hydantoin 3-phenyl-5-(4-ethylphenyl)-imidazolidine-2,4-dione in mice.

Imidazolidine derivatives, or hydantoins, are synthetic compounds with different therapeutic applications. Many imidazolidine derivatives have psychopharmacological properties, such as phenytoin, famous for its anticonvulsant efficacy, but also effective in the treatment of neuropathic pain. The hydantoin, 3-phenyl-5-(4-ethylphenyl)-imidazolidine-2,4-dione (IM-3), synthesized from the amino acid, glycine, was selected for psychopharmacological studies in mice on the basis of its chemical and structural similarity with phenytoin. The first step of this study was to define the LD50, which determined the doses of 50, 100 and 200 mg/kg for subsequent tests. The results obtained from the behavioral screening indicated that IM-3 produces decreased ambulation and analgesia in mice. Motor coordination and anxiety behavior were not affected by treatment with IM-3, as observed in the rotarod and elevated plus-maze tests, respectively. Regarding its antinociceptive properties, IM-3 showed efficacy in the acetic acid-induced writhing test by increasing the latency of the first writhe and reducing the number of writhes, as well as reducing the paw licking time in the second phase of the formalin test. The behavior of treated animals exposed to the hot plate test, however, did not differ from that of the control group. These data suggest that IM-3 has antinociceptive effects in mice, which is probably mediated by anti-inflammatory mechanisms.